BCL-2 TARGETED STRUCTURAL BASED COMPUTER AIDED DRUG DESIGN (CAAD) FOR THERAPEUTIC ASSESSMENT OF RICIN IN PROSTATE CANCER. Int. J. Pharm. Sci. Drug Res. [Internet]. 2018 Sep. 1 [cited 2025 Sep. 21];7(2):168-71. Available from: https://ijpsdronline.com/index.php/journal/article/view/406